ImmunityBio
IBRX
IBRX
116 hedge funds and large institutions have $109M invested in ImmunityBio in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 23 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-29
Holders Change %
-20%
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
50
Reduced
23
Closed
44
Calls
$10.5M
Puts
$8.69M
Net Calls
+$1.86M
Net Calls Change
+$1.8M
Top Buyers
| 1 |
1
BlackRock
New York
|
$26.4M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$28.7M |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$7.59M |
| 4 |
4
National Bank of Canada
Montreal,
Quebec, Canada
|
$2.18M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$3.23M |
